In the high-DLC1 expression group, tumor immunity-related signaling pathways, such as Wnt signaling pathway, leukocyte transendothelial migration, and JAK–STAT signaling pathway, were markedly enriched. This evidence concerns the gene DLC1 and neoplasm.